| UNC2025 |
反式-4-[2-(丁基氨基)-5-[4-[(4-甲基-1-哌嗪基)甲基]苯基]-7H-吡咯并[2,3-D]嘧啶-7-基]-环己醇 |
1429881-91-3 |
| Tazemetostat (EPZ-6438) |
EPZ-6438 |
1403254-99-8 |
| G007-LK |
G007-LK |
1380672-07-0 |
| CO-1686 |
CO1686 |
1374640-70-6 |
| TUG 891 |
TUG 891 |
1374516-07-0 |
| S)-1-(sec-butyl)-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-3-Methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxaMide |
GSK126 |
1346574-57-9 |
| PF-04554878 |
DEFACTINIB (VS-6063, PF-04554878) |
1345713-71-4 |
| Volitinib |
沃利替尼 |
1313725-88-0 |
| GDC-0032 |
GDC 0032 |
1282512-48-4 |
| NMS-P118 |
2-[1-(4,4-二氟环己基)-4-哌啶基]-6-氟-2,3-二氢-3-氧代-1H-异吲哚-4-甲酰胺 |
1262417-51-5 |
| LY 2874455 |
LY2874455 |
1254473-64-7 |
| Tubastatin-A |
TUBASTATIN A |
1252003-15-8 |
| HM-61713 (BI-1482694) |
HM-61713(BI-1482694) |
1802181-20-9 |
| Methyl 4-Fluoro-2-{1H-pyrrolo[2,3-b]pyridin-5-yloxy}benzoate |
ABT-199中间体 |
1235865-75-4 |
| LY 2606368 |
5-[[5-[2-(3-氨基丙氧基)-6-甲氧基苯基]-1H-吡唑-3-基]氨基]-2-吡嗪甲腈 |
1234015-52-1 |
| Abemaciclib |
阿贝西利 |
1231929-97-7 |
| 4-((2,4-difluoro-5-((2R,3S)-3-(5-fluoropyrimidin-4-yl)-2-hydroxy-1-(1H-1,2,4-triazol-1-yl)butan-2-yl)phenyl)amino)-4-oxobutanoic acid |
VOR-5 |
1620283-05-7 |
| EPZ015666 |
EPZ015666 |
1616391-65-1 |
| 5-(4-aMino-1-isopropyl-1H-pyrazolo[3,4-d]pyriMidin-3-yl)benzo[d]oxazol-2-aMine |
3-(2-氨基-5-苯并恶唑基)-1-(1-甲基乙基)-1H-吡唑并[3,4-D]嘧啶-4-胺 |
1224844-38-5 |
| N-(3-{2-[3-Fluoro-4-(4-methyl-piperazin-1-yl)-phenylamino]-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy}-phenyl)-acrylamide |
艾维替尼 |
1557267-42-1 |
QQ
微信
